{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:41:41Z","timestamp":1791348101802,"version":"4.3.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Startup Fund for Scientific Research by Fujian Medical University 2022","award":["Grant No.2022QH1326"],"award-info":[{"award-number":["Grant No.2022QH1326"]}]},{"name":"Fujian Natural Science Foundation 2019","award":["Grant No. 2019J01186"],"award-info":[{"award-number":["Grant No. 2019J01186"]}]},{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["Grant No. 2019-CX-11"],"award-info":[{"award-number":["Grant No. 2019-CX-11"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05577-3","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T04:55:21Z","timestamp":1770180921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Two diseases presenting only as cardiac hypertrophy: differences between the late-onset Fabry disease cardiac variant and hypertrophic cardiomyopathy"],"prefix":"10.1186","volume":"26","author":[{"given":"Lirong","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangxin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dusheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"issue":"3","key":"5577_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ymgme.2018.06.004","volume":"124","author":"C Wanner","year":"2018","unstructured":"Wanner C, Arad M, Baron R, et al. European expert consensus statement on therapeutic goals in Fabry disease. Mol Genet Metab. 2018;124(3):189\u2013203.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"5577_CR2","first-page":"91","volume":"130","author":"M Nowicki","year":"2020","unstructured":"Nowicki M, Bazan-Socha S, B\u0142a\u017cejewska-Hyzorek B, et al. Enzyme replacement therapy in Fabry disease in poland: a position statement. Pol Arch Intern Med. 2020;130(1):91\u20137.","journal-title":"Pol Arch Intern Med"},{"issue":"1","key":"5577_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jjcc.2007.12.001","volume":"51","author":"T Takenaka","year":"2008","unstructured":"Takenaka T, Teraguchi H, Yoshida A, et al. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study. J Cardiol. 2008;51(1):50\u20139.","journal-title":"J Cardiol"},{"issue":"4","key":"5577_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.acvd.2019.01.002","volume":"112","author":"A Hag\u00e8ge","year":"2019","unstructured":"Hag\u00e8ge A, R\u00e9ant P, Habib G, et al. Fabry disease in cardiology practice: literature review and expert point of view. Arch Cardiovasc Dis. 2019;112(4):278\u201387.","journal-title":"Arch Cardiovasc Dis"},{"issue":"4","key":"5577_CR5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/mgg3.389","volume":"6","author":"DP Germain","year":"2018","unstructured":"Germain DP, Brand E, Burlina A, et al. Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry registry study. Mol Genet Genomic Med. 2018;6(4):492\u2013503.","journal-title":"Mol Genet Genomic Med"},{"issue":"2","key":"5577_CR6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ymgme.2019.07.012","volume":"129","author":"O Azevedo","year":"2020","unstructured":"Azevedo O, Gal A, Faria R, et al. Founder effect of Fabry disease due to p.F113L mutation: clinical profile of a late-onset phenotype. Mol Genet Metab. 2020;129(2):150\u201360.","journal-title":"Mol Genet Metab"},{"issue":"23","key":"5577_CR7","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1016\/j.jacc.2016.09.943","volume":"68","author":"TR Hsu","year":"2016","unstructured":"Hsu TR, Hung SC, Chang FP, et al. Later onset Fabry Disease, cardiac damage progress in silence: experience with a highly prevalent mutation. J Am Coll Cardiol. 2016;68(23):2554\u201363.","journal-title":"J Am Coll Cardiol"},{"issue":"8 Pt 2","key":"5577_CR8","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.jcmg.2018.03.020","volume":"12","author":"S Nordin","year":"2019","unstructured":"Nordin S, Kozor R, Medina-Menacho K, et al. Proposed stages of myocardial phenotype development in Fabry disease. JACC Cardiovasc Imaging. 2019;12(8 Pt 2):1673\u201383.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"45","key":"5577_CR9","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1093\/eurheartj\/ehad581","volume":"44","author":"J Wang","year":"2023","unstructured":"Wang J, Yang S, Ma X, et al. Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines. Eur Heart J. 2023;44(45):4781\u201392.","journal-title":"Eur Heart J"},{"issue":"4","key":"5577_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jjcc.2022.05.003","volume":"80","author":"T Kubo","year":"2022","unstructured":"Kubo T, Amano M, Takashio S, et al. A retrospective investigation to Establish new screening approach for the detection of patients at high risk of Fabry disease in male left ventricular hypertrophy patients. J Cardiol. 2022;80(4):325\u201331.","journal-title":"J Cardiol"},{"issue":"3","key":"5577_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233\u201370. \\.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"5577_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr. 2015;28(1):1\u2013e3914.","journal-title":"J Am Soc Echocardiogr"},{"issue":"11","key":"5577_CR13","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1111\/echo.14508","volume":"36","author":"S Militaru","year":"2019","unstructured":"Militaru S, Jurcu\u021b R, Adam R, Ro\u015fca M, Ginghina C, Popescu BA. Echocardiographic features of Fabry cardiomyopathy-Comparison with hypertrophy-matched sarcomeric hypertrophic cardiomyopathy. Echocardiography. 2019;36(11):2041\u20139.","journal-title":"Echocardiography"},{"issue":"4","key":"5577_CR14","first-page":"321","volume":"60","author":"Chinese Fabry Disease Expert Panel","year":"2021","unstructured":"Chinese Fabry Disease Expert Panel. [Expert consensus for diagnosis and treatment of Fabry disease in China (2021)]. Zhonghua Nei Ke Za Zhi. 2021;60(4):321\u201330.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"5","key":"5577_CR15","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCGENETICS.109.862920","volume":"2","author":"HY Lin","year":"2009","unstructured":"Lin HY, Chong KW, Hsu JH, et al. High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population. Circ Cardiovasc Genet. 2009;2(5):450\u20136.","journal-title":"Circ Cardiovasc Genet"},{"issue":"4","key":"5577_CR16","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1086\/339431","volume":"70","author":"S Ishii","year":"2002","unstructured":"Ishii S, Nakao S, Minamikawa-Tachino R, Desnick RJ, Fan JQ. Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype. Am J Hum Genet. 2002;70(4):994\u20131002.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"5577_CR17","first-page":"337","volume":"37","author":"CL Hung","year":"2021","unstructured":"Hung CL, Wu YW, Lin CC, Lai CH, Jyh-Ming Juang J, Chao TH, et al. 2021 TSOC expert consensus on the clinical Features, Diagnosis, and clinical management of cardiac manifestations of Fabry disease. Acta Cardiol Sin. 2021;37(4):337\u201354.","journal-title":"Acta Cardiol Sin"},{"key":"5577_CR18","doi-asserted-by":"crossref","unstructured":"Zhao M, Niu X, Bai L et al. Unexplained left ventricular hypertrophy diagnosed as a cardiac variant of Late-Onset Fabry disease: A case report. J Cardiovasc Dev Dis. 2023;10(9):389.","DOI":"10.3390\/jcdd10090389"},{"issue":"6","key":"5577_CR19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1136\/hrt.2010.211789","volume":"97","author":"M Namdar","year":"2011","unstructured":"Namdar M, Steffel J, Vidovic M, et al. Electrocardiographic changes in early recognition of Fabry disease. Heart. 2011;97(6):485\u201390.","journal-title":"Heart"},{"issue":"8\u20139","key":"5577_CR20","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.acvd.2020.04.008","volume":"113","author":"N Junqua","year":"2020","unstructured":"Junqua N, Legallois D, Segard S, Lairez O, R\u00e9ant P, Goizet C, et al. The value of electrocardiography and echocardiography in distinguishing Fabry disease from sarcomeric hypertrophic cardiomyopathy. Arch Cardiovasc Dis. 2020;113(8\u20139):542\u201350.","journal-title":"Arch Cardiovasc Dis"},{"key":"5577_CR21","doi-asserted-by":"crossref","unstructured":"Sayed ME, Postema PG, Datema M, van Dussen L, Kors JA, Haar CCT et al. ECG changes during adult life in Fabry disease: results from a large longitudinal cohort study. Diagnostics (Basel). 2023;13(3):354.","DOI":"10.3390\/diagnostics13030354"},{"issue":"7","key":"5577_CR22","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/ejhf.1960","volume":"22","author":"A Linhart","year":"2020","unstructured":"Linhart A, Germain DP, Olivotto I, et al. An expert consensus document on the management of cardiovascular manifestations of Fabry disease. Eur J Heart Fail. 2020;22(7):1076\u201396.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"5577_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/hrt.68.9.323","volume":"68","author":"Y Ikari","year":"1992","unstructured":"Ikari Y, Kuwako K, Yamaguchi T. Fabry\u2019s disease with complete atrioventricular block: histological evidence of involvement of the conduction system. Br Heart J. 1992;68(3):323\u20135.","journal-title":"Br Heart J"},{"issue":"6","key":"5577_CR24","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.2353\/ajpath.2008.070576","volume":"172","author":"C Chimenti","year":"2008","unstructured":"Chimenti C, Hamdani N, Boontje NM, et al. Myofilament degradation and dysfunction of human cardiomyocytes in Fabry disease. Am J Pathol. 2008;172(6):1482\u201390.","journal-title":"Am J Pathol"},{"issue":"5","key":"5577_CR25","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1365-2559.2004.01835.x","volume":"44","author":"SE Hughes","year":"2004","unstructured":"Hughes SE. The pathology of hypertrophic cardiomyopathy. Histopathology. 2004;44(5):412\u201327.","journal-title":"Histopathology"},{"issue":"3","key":"5577_CR26","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1161\/CIRCIMAGING.112.000070","volume":"6","author":"DM Sado","year":"2013","unstructured":"Sado DM, White SK, Piechnik SK, et al. Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance Noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging. 2013;6(3):392\u20138.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"5577_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12968-014-0099-4","volume":"16","author":"S Pica","year":"2014","unstructured":"Pica S, Sado DM, Maestrini V, et al. Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2014;16(1):99.","journal-title":"J Cardiovasc Magn Reson"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05577-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05577-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05577-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T11:21:10Z","timestamp":1772623270000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05577-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5577"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05577-3","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Fuzhou University Affiliated Provincial Hospital (Approval No. K2023-06-016) and was conducted in accordance with the Declaration of Helsinki. All study subjects obtained informed consent and written consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"196"}}